US EditionDrugmaker files emergency appeal to restore access to mail-order abortion pill mifepristone
Danco says the ruling would disrupt access for patients and providers and threaten its only product, which accounts for about 65% of clinician-provided abortions.
- On Saturday, Danco Laboratories filed an emergency request with the Supreme Court to immediately pause a lower court ruling that blocks mail-order access to mifepristone. The filing seeks to restore nationwide telehealth distribution of the abortion drug.
- The Fifth Circuit Court of Appeals ruled Friday that Louisiana was likely to prevail in its challenge, essentially reimposing an FDA requirement for in-person medical exams. The panel argued the 2023 rule change lacked scientific basis.
- Danco argued the ruling "injects immediate confusion and upheaval into highly time-sensitive medical decisions," forcing providers and pharmacies to guess what is allowed. The company warned the nationwide ban threatens Mifeprex, its only revenue source.
- Medication abortion accounts for nearly two-thirds of U.S. abortions, and the ruling significantly curbs access in states that have banned the procedure. Nearly half of all states have restricted abortion since the Supreme Court's 2022 decision.
- Drugmakers could ask the full Fifth Circuit to reconsider or appeal to the 6-3 conservative-majority Supreme Court. The Trump administration is reviewing mifepristone safety, a process expected to extend beyond the midterm elections.
209 Articles
209 Articles
Hastings Tribune
union-bulletin.comSupreme Court asked to restore access to mail-order abortion pills
Massachusetts Gov. Maura Healey joined calls across the nation urging the Supreme Court to immediately reverse the decision to cut access to mailing the abortion medication mifepristone after an appeals court ruling over the weekend.
LifeNews.com
littlebytesnews.comAbortion Pill Makers Ask Supreme Court to Allow Mail-Order Abortions
The makers of the abortion pill mifepristone asked the Supreme Court on Saturday to overturn a federal appeals court ruling that temporarily blocks the mailing of the drug nationwide. The ruling has the potential to save tens of thousands of babies from abortions and thousands of women from medical problems or even death. But abortion drug maker Danco Laboratories filed an emergency application seeking to lift the U.S. Court of Appeals for the 5…
Danco Laboratory, one of the two companies distributing the abortive pill in the United States, on Saturday asked the United States Supreme Court to suspend the decision to temporarily block the drug.
Two manufacturers of mifepristone, a widely used abortion pill, asked the U.S. Supreme Court on Saturday to block a ruling by a federal appeals court.
The Times of Northwest Indiana
Company asks high court to stay abortion ruling
Pharmaceutical company Danco Laboratories filed an application Saturday with the U.S. Supreme Court seeking a stay of an appeals court ruling that temporarily blocked the abortion drug mifepristone from being dispensed through the mail.
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
